The Metabolism of Human Mesenchymal Stem Cells During Proliferation and Differentiation
Overview
Physiology
Affiliations
Human mesenchymal stem cells (MSCs) reside under hypoxic conditions in vivo, between 4% and 7% oxygen. Differentiation of MSCs under hypoxic conditions results in inhibited osteogenesis, while chondrogenesis is unaffected. The reasons for these results may be associated with the inherent metabolism of the cells. The present investigation measured the oxygen consumption, glucose consumption and lactate production of MSCs during proliferation and subsequent differentiation towards the osteogenic and chondrogenic lineages. MSCs expanded under normoxia had an oxygen consumption rate of ∼98 fmol/cell/h, 75% of which was azide-sensitive, suggesting that these cells derive a significant proportion of ATP from oxidative phosphorylation in addition to glycolysis. By contrast, MSCs differentiated towards the chondrogenic lineage using pellet culture had significantly reduced oxygen consumption after 24 h in culture, falling to ∼12 fmol/cell/h after 21 days, indicating a shift towards a predominantly glycolytic metabolism. By comparison, MSCs retained an oxygen consumption rate of ∼98 fmol/cell/h over 21 days of osteogenic culture conditions, indicating that these cells had a more oxidative energy metabolism than the chondrogenic cultures. In conclusion, osteogenic and chondrogenic MSC cultures appear to adopt the balance of oxidative phosphorylation and glycolysis reported for the respective mature cell phenotypes. The addition of TGF-β to chondrogenic pellet cultures significantly enhanced glycosaminoglycan accumulation, but caused no significant effect on cellular oxygen consumption. Thus, the differences between the energy metabolism of chondrogenic and osteogenic cultures may be associated with the culture conditions and not necessarily their respective differentiation.
Zhou H, Xiang W, Zhou G, Rodrigues-Lima F, Guidez F, Wang L Med Oncol. 2024; 42(1):23.
PMID: 39644425 DOI: 10.1007/s12032-024-02575-3.
Rozycka-Baczynska A, Stepaniec I, Warzycha M, Zdolinska-Malinowska I, Oldak T, Rozwadowska N J Appl Genet. 2024; .
PMID: 39621192 DOI: 10.1007/s13353-024-00917-5.
Campbell J, Mahbub S, Anwer A, Habibalahi A, Gronthos S, Paton S Cells. 2024; 13(20.
PMID: 39451249 PMC: 11505937. DOI: 10.3390/cells13201731.
Donnelly H, Ross E, Xiao Y, Hermantara R, Taqi A, Doherty-Boyd W Nat Commun. 2024; 15(1):5791.
PMID: 38987295 PMC: 11237034. DOI: 10.1038/s41467-024-50054-0.
How aging influences the gut-bone marrow axis and alters hematopoietic stem cell regulation.
Wells C, Robertson T, Sheth P, Abraham S Heliyon. 2024; 10(12):e32831.
PMID: 38984298 PMC: 11231543. DOI: 10.1016/j.heliyon.2024.e32831.